Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-3.41%)
As of: Oct 23, 2026 · 3:50 PM EDT

Mereo BioPharma (MREO) Revenue (2023 - 2026)

Updated

Mereo BioPharma's Revenue was $500,000 in FY2025.

Analysis

Mereo BioPharma (MREO) Revenue (2023 - 2026) Analysis & Trends

  • Revenue shows a four-year compound annual growth rate of -68.2% (FY2021 to FY2025).
  • Per Business Quant data, Revenue in earlier years was $10 million in FY2023 and $49.15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,133.26 Bn 1,101.85 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 635.92 Bn 555.78 Bn 17.30 Bn 25.40 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn 16.99 Bn
4 Merck 358.38 Bn 312.76 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 293.00 Bn 256.99 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.76 Bn 239.44 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.88 Bn 193.27 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 195.26 Bn 169.45 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn 15.03 Bn
10 Mereo BioPharma 44.55 Mn -105.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 11,000.00
Jun 30, 2025 500,000.00
Mar 31, 2025 -180,000.00
Dec 31, 2023 1.00 Mn
Jun 30, 2023 9.00 Mn
API Access

Mereo BioPharma Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=MREO&period=max&api_key=YOUR_API_KEY